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Abstract
Introduction The FloTrac/Vigileo™ (Edwards Lifesciences,
Irvine, CA, USA) allows pulse pressure-derived cardiac output
measurement without external calibration. Software
modifications were performed in order to eliminate initially
observed deficits. The aim of this study was to assess changes
in cardiac output determined by the FloTrac/Vigileo™ system
(FCO) with an initially released (FCOA) and a modified (FCOB)
software version, as well as changes in cardiac output from the
PiCCOplus™ system (PCO; Pulsion Medical Systems, Munich,
Germany). Both devices were compared with cardiac output
measured by intermittent thermodilution (ICO).
Methods Cardiac output measurements were performed in
patients after elective cardiac surgery. Two sets of data (A and
B) were obtained using FCOA and FCOB in 50 patients. After
calibration of the PiCCOplus™ system, triplicate FCO and PCO
values were recorded and ICO was determined in the supine
position and cardiac output changes due to body positioning
were recorded 15 minutes later (30° head-up, 30° head-down,
supine). Student's t test, analysis of variance and Bland-Altman
analysis were calculated.
Results Significant changes of FCO, PCO and ICO induced by
body positioning were observed in both data sets. For set A,
ΔFCOA was significantly larger than ΔICO induced by
positioning the head down. For set B, there were no significant
differences between ΔFCOB and ΔICO. For set A, increased
limits of agreement were found for FCOA-ICO when compared
with PCO-ICO. For set B, mean bias and limits of agreement
were comparable for FCOB-ICO and PCO-ICO.
Conclusions The modification of the FloTrac/Vigileo™ system
resulted in an improved performance in order to reliably assess
cardiac output and track the related changes in patients after
cardiac surgery.
Introduction
Cardiac output is monitored in critically ill patients to assess
cardiac function in order to maintain adequate tissue per-
fusion. In order to accomplish this task the thermodilution tech-
nique using a pulmonary artery catheter has been used for
decades as the clinical standard. However, based on results
of different studies, its use has been questioned and there is
an ongoing debate on its impact on patient outcome [1-3].
Several alternative, less invasive techniques are available
today, with cardiac output derived from pulse pressure being
one of the most used methods [4].
Continuous pulse contour analysis by the PiCCOplus™ sys-
tem (Pulsion Medical Systems, Munich, Germany) assesses
arterial pressure waveforms using a specific thermistor tipped
catheter typically inserted into the femoral artery. Cardiac out-
put is calculated using an algorithm measuring the area under
the curve of the systolic pressure wave after calibration by
transpulmonary thermodilution. Moreover, the calibration proc-
ess is used to adapt for individual vascular compliance. The
PiCCOplus™ system has been repeatedly shown to reliably
assess for cardiac output in different clinical situations [5-7].
However, inaccurate measurements during haemodynamic
changes were observed with the initial pulse contour algorithm
[8] and the technique has been modified to better address the
aortic compliance in these situations [9,10].
CVP: central venous pressure; FCO: cardiac output determined by the FloTrac/Vigileo™ system; HR: heart rate; ICO: cardiac output determined by 
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The recently introduced FloTrac/Vigileo™ system (Edwards
Lifesciences, Irvine, CA, USA) on the other hand allows the
cardiac output to be determined continuously using pulse
wave analysis without external calibration. It samples pressure
wave signals using a standard peripheral arterial line. The
standard deviation of pulse pressure is empirically correlated
to the stroke volume based on patient characteristics after
automatic adjustment for actual vascular compliance and dis-
played as continuous cardiac output. Initial evaluation studies
on the FloTrac/Vigileo™ system revealed conflicting results
[11-13].
The observed weak or only fair agreement between the new
system and a reference technique may be partly explained by
the fact that adaption for changes of vascular compliance at
10 minute intervals may miss haemodynamic changes during
that time window. Consequently, the FloTrac/Vigileo™ system
with its underlying algorithm has been improved and – as a
major modification – the time window was reduced to one
minute (Software version 1.07 and higher). Consecutive stud-
ies using a modified FloTrac/Vigileo™ system showed
improved results [14-18]. However, methodological issues
regarding the study design (i.e. set-up of monitoring devices,
predefined measurement points during the perioperative
course of cardiac surgery, measurements taken early after car-
diopulmonary bypass) may impede a reliable trend analysis.
Moreover, comparisons of different FloTrac/Vigileo™ software
versions in a clearly defined setting during haemodynamic
changes have not been performed so far.
The aim of the present study was to assess cardiac output and
the related changes determined by two pulse contour analysis
devices after induction of haemodynamic changes by body
positioning. The FloTrac/Vigileo™ system with an initially
released and a modified software version, as well as the PiC-
COplus™ system were used in patients after off-pump coro-




With local ethics committee approval, patients scheduled for
elective off-pump coronary artery bypass grafting were
enrolled in this study after written informed consent was
obtained. Exclusion criteria were reduced left and right ven-
tricular function (ejection fraction less than 40%), preoperative
dysrhythmias, severe valvular heart diseases, intracardiac
shunts, pulmonary artery hypertension, severe arterial occlu-
sion disease and body weight less than 40 kg. A total of 50
patients were enrolled and cardiac output was determined by
the FloTrac/Vigileo™ system (FCO), 25 patients using
FloTrac/Vigileo™ software version 1.03 (FCOA) and 25
patients using software version 1.07 (FCOB), set A and B,
respectively. The sample size was determined on the hypothe-
sis of an expected standard deviation of 8% for cardiac output
values and an expected difference in the range of the standard
deviation between the values of the different measurement
techniques (α = 0.05 and power > 0.9).
Routine perioperative management
Perioperative management was performed according to insti-
tutional standards. Routine monitoring (Philips IntelliVue™
Monitoring; Philips Medical Systems, Andover, MA, USA) dur-
ing the entire perioperative period included pulse oxymetry,
five-lead ECG, invasive blood pressure measurement via a
peripheral radial arterial and central venous pressure (CVP)
assessed by standard transducers (Truewave™ PX; Edwards
Lifesciences, Irvine, CA, USA). At the time the study was per-
formed the PiCCOplus™ system was the routine continuous
cardiac output monitoring system in the selected patient
group according to institutional standards. After induction of
anaesthesia a 4F thermistor-tipped arterial catheter (Pulsio-
cath™ thermodilution catheter) was inserted into the left femo-
ral artery, its tip advanced to the abdominal aorta and
connected to the stand-alone computer PiCCOplus™ (Version
6.0; Pulsion Medical Systems, Munich, Germany). Intraopera-
tive continuous cardiac output measurement was initiated
after the initial calibration of the system using a 20 ml ice-cold
normal saline injection via a standard central venous catheter
in triplicate.
Study setting
Measurements were started in the postoperative period after
transfer of the patients to the intensive care unit. The patients
remained sedated during the study period using propofol and
remifentanil infusion. Rocuronium (0.2 to 0.5 mg/kg/hour) for
neuromuscular blockade was administered when needed.
Mean arterial pressure (MAP) was kept between 65 and 75
mmHg adjusting the patient's noradrenaline dose (0 to 10 μg/
minute). No other catecholamines had to be used during the
study period. In order to maintain regular heart rhythm in all
patients, fixed external pacing at a heart rate (HR) between 80
and 90 beats/minute was used. The patients' lungs were
mechanically ventilated using a volume-controlled mode (tidal
volume = 6 to 8 ml/kg, respiratory frequency = 12 breaths/
minute, positive end-expiratory pressure = 5 cmH2O, peak
inspiratory pressure = 18 to 25 cmH2O) in order to achieve
normoventilation (partial pressure of carbon dioxide = 4 to 4.5
kPa).
Weaning from the ventilator was started after completion of
the study protocol. The femoral PiCCO™ catheter introduced
after induction of anaesthesia was connected to the stand-
alone monitor PiCCOplus™ (computer version 5.2.2; Pulsion
Medical Systems, Munich, Germany) and calibrated according
to the manufacturer's instruction. A FloTrac™ sensor kit was
connected to the radial arterial line and connected to the Vig-
ileo™ (Edwards Lifesciences, Irvine, CA, USA). For set A, soft-
ware version 1.03 was used and for set B software version
1.07 was used. Individual patient data were entered includingAvailable online http://ccforum.com/content/13/2/R32
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age (years), gender, body weight (kg) and height (cm). Meas-
urements were initiated after checking the arterial line wave-
form fidelity and zeroing the system at mid-axillary level to
ambient pressure.
Pulse wave analysis algorithms
Cardiac output is assessed by the FloTrac/Vigileo™ and PiC-
COplus™ systems using different proprietary algorithms.
These have been described in detail elsewhere [6,15]. Briefly,
the calculation of cardiac output by the FloTrac/Vigileo™ sys-
tem is based on the contribution of pulse pressure on cardiac
output being proportional to the standard deviation of arterial
pulse pressure. The influence of vascular resistance and com-
pliance on cardiac output is considered manually based on
entered patient data. Thus, there is no need for external cali-
bration. By contrast, the PiCCOplus™ method relies on the
work of Wesseling and colleagues [19] calculation of cardiac
output by measuring the area under the curve of the systolic
arterial pressure wave form and dividing this area by the aortic
impedance after calibration by transpulmonary thermodilution.
For adequate determination of cardiac output and the adjust-
ment of individual aortic compliance, however, calibration by
transpulmonary thermodilution is required.
Study protocol
Haemodynamic measurements were performed in the follow-
ing positions: in supine position (haemodynamic stability); 15
minutes after initiation of a 30° head-up position; 15 minutes
after tilting the patient's bed to a 30° head-down position; and
15 minutes after adjusting the patient into a supine position
again. At all four time points the following haemodynamic vari-
ables were recorded: MAP, HR, CVP, FCO and cardiac output
readings from the PiCCOplus™ system (PCO). Immediately
thereafter, triplicate transpulmonary thermodilution measure-
ments of 20 ml normal iced saline solution were performed to
determine cardiac output measured by intermittent thermodi-
lution (ICO). Post-hoc systemic vascular resistance (SVR) was
calculated (Figure 1). No recalibration of the PiCCOplus™ was
performed during the study period.
Statistics
All haemodynamic variables were recorded as a mean of three
repeated measurements. Statistical analysis was performed
using Statview 5.01® Software (SAS Institute Inc., Cary, NC,
USA) and SPSS® 10.0 (SPSS Inc., Chicago, IL, UK). Cardiac
output changes were calculated as percentage deviation of
the previous measurements. Analysis of variance for repeated
measurements (post-hoc Bonferroni correction) was used to
assess differences of haemodynamic variables during the
study period. Paired student's t-test and Bland-Altman analy-
sis (including percentage error according to Critchley and
Critchley [20]) was performed to compare cardiac output val-
ues obtained by the different devices and cardiac output
assessed by intermittent thermodilution. Unless otherwise
stated, data are presented as mean ± standard deviation.
Results
A total of 50 American Society of Anesthesiologists (ASA)
physical status III patients with preserved left ventricular func-
tion undergoing elective cardiac bypass surgery were enrolled
(Table 1). In total, 100 matched sets of data were obtained for
both sets. Sociodemographic characteristics are summarised
in Table 1.
During the study period (Figure 1) significant haemodynamic
changes after changing body positioning were observed for
both sets of data (Table 2). Based on a fixed external pacing
rate no changes in HR were observed. FCO, PCO and ICO
significantly decreased after inducing a head-up position and
significantly increased when tilting the patient into the head-
down position. For all measurements, the direction of FCO,
PCO and ICO changes were similar. For set A, there was a
significant difference between the changes of FCO and ICO
when inducing the 30° head-down position. For set B no sig-
nificant differences were observed between FCO and ICO,
Figure 1
Study protocol Study protocol. Set A was FCO assessed using the software version 1.03, and set B was FCO assessed using the software version 1.07. 
FCO = cardiac output assessed by the FloTrac/Vigileo™ device; ICO = cardiac output determined by the intermittent thermodilution; PCO = car-
diac output assessed by the PiCCOplus™ system.Critical Care    Vol 13 No 2    Senn et al.
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whereas changes of PCO significantly underestimated ICO
creating decreases and increases of cardiac output by body
positioning (Figure 2).
Bland-Altman analysis for the comparison of FCO and ICO
revealed an overall mean bias and limits of agreement of -0.1
± 2.1 L/minute for set A and -0.3 ± 1.1 L/minute for set B.
Total percentage error for set A was 37.5%, analysis for each
measurement point revealed a percentage error less than 30%
for the initial assessment in a supine position (Table 3). A total
percentage error of 21.6 % was found for set B. For all meas-
urement points a percentage error less than 30% was found
(Table 3) and limits of agreement were lower for set B when
compared with set A (Figure 3).
Comparison of PCO with ICO showed low limits of agreement
and percentage error less than 30% for all measurement.
Overall mean bias, limits of agreement and percentage error
were -0.2 ± 1.4 L/minute and 25% for set A, and -0.2 ± 1.3 L/
minute and 25.5% for set B, respectively (Table 3 and Figure
4).
Discussion
In this study we evaluated cardiac output assessed by an ini-
tially released and a modified version of the FloTrac/Vigileo™,
the PiCCOplus™ system and the bolus thermodilution – as ref-
erence technique – during haemodynamic changes induced
by body positioning in patients after elective off-pump coro-
nary artery bypass surgery. The modified FloTrac/Vigileo™ sys-
tem showed an improved performance as compared with the
early version of the system and measurements were as reliable
as those performed by the PiCCOplus™ in this setting.
Cardiac output measurements by both less invasive monitor-
ing devices used in this study rely on pulse pressure analysis.
Although pulse pressure results from an interaction of the
heart (cardiac output) and the vascular system, the influence
of vascular properties and changes (resistance, impedance
and compliance) have to be considered in the algorithms of
the devices in order to reliably derive cardiac output. The
FloTrac/Vigileo™ system calculates cardiac output analysing
the impact of vascular tone on pressure and adjusts for actual
vascular tone based on wave form analysis and patient char-
acteristics. Therefore, compared with other pulse contour
devices, it does not require any external calibration method or
subsequent correction and may therefore avoid operator bias.
Studies validating the FloTrac/Vigileo™ system in cardiac sur-
gery patients showed conflicting results using early software
versions. In only one study were acceptable results regarding
cardiac output measurements reported [11]. By contrast,
Mayer and colleagues found in their study only a moderate
agreement [12], whereas Sander and colleagues observed a
weak agreement between the FloTrac/Vigileo™ system and
intermittent thermodilution measurement in cardiac surgery
patients [13]. Based on the initial clinical experience and the
early validation studies the FloTrac algorithm was adapted to
better address the issue of rapid haemodynamic changes.
The initial software version adjusted every 10 minutes for
changes of vascular compliance, resistance and impedance.
This time window was reduced to one minute for the software
version 1.07 and higher as a major modification in order to
improve cardiac output measurement. The studies performed
with the modified FloTrac/Vigileo™ system revealed better
results comparing cardiac output determined by this pulse
wave analysis device with the standard intermittent thermodi-
lution technique [14-18]. Our study group showed that periop-
erative performance of the FloTrac/Vigileo™ system, the
PiCCOplus™ system and also the continuous cardiac output
monitoring by the Vigilance monitoring based on the pulmo-
nary artery catheter (Edwards Lifesciences, Irvine, CA, USA)
was comparable in 31 patients undergoing elective coronary
artery bypass surgery [15]. These findings were supported by
a recently published study by Mayer and colleagues per-
formed in a perioperative setting in 40 cardiac surgery patients
[17]. Based on the study design, however, these studies were
not able to directly demonstrate that the modifications of the
FloTrac™ algorithm allow an improved monitoring and tracking
of cardiac output changes. In the present study we induced
haemodynamic changes by body positioning and using this
approach we could show that cardiac output assessment by
the initial FloTrac™ algorithm was insufficient in terms of
increased limits of agreement and a percentage error higher
than 30% (according to Critchley and Critchley [20]) when
compared with the intermittent thermodilution method. By
contrast, limits of agreement and percentage error were
clearly reduced when cardiac output was measured by the
modified algorithm. Moreover, changes of cardiac output were
comparable with the reference technique.
Overall bias and limits of agreement of the PiCCOplus™ sys-
tem were comparable with findings in previously published
work [8-11]. For all data sets percentage error was lower than
Table 1
Sociodemographic data
Set A Set B P value
Age (years) 64.7 (10.6) 66.6 (7.6) 0.386
Female/male ratio 5/20 6/19 0.791
BMI (kg/m2) 26.6 (3.5) 27.9 (3.6) 0.208
EURO score 4.0 (3.0) 4.0 (2.0) 0.635
Preoperative EF (%) 58.0 (11.6) 57.2 (9.2) 0.685
CABG off 4.0 (1.0) 4.0 (1.0) 0.430
BMI = body mass index; CABG off = off-pump coronary artery 
bypass grafting; EF = ejection fraction; EURO = European System 
for Cardiac Operative Risk Evaluation.Available online http://ccforum.com/content/13/2/R32
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Figure 2
Cardiac output changes assessed during the study period Cardiac output changes assessed during the study period. Set A was FCO assessed using the software version 1.03, and set B was FCO 
assessed using the software version 1.07. 
FCO = cardiac output assessed by the FloTrac/Vigileo™ device; ICO = cardiac output determined by the intermittent thermodilution; PCO = car-
diac output assessed by the PiCCOplus™ system.Critical Care    Vol 13 No 2    Senn et al.
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30% when compared with intermittent thermodilution. Thus,
our results demonstrate an adequate performance of the PiC-
COplus™ system when inducing cardiac output changes by
body positioning. In contrast to the FloTrac/Vigileo™ system,
however, the PiCCOplus™ system showed a trend to under-
estimate cardiac output changes assessed by the reference
technique. This was statistically significant for two changes in
set B, but may not necessarily be considered as clinically rel-
evant regarding the general performance of the PiCCOplus™
during the study. An operator error can be excluded, because
the PiCCOplus™ system was recalibrated by the same
observer according to the manufacturer's instructions. Moreo-
ver, optimal arterial signal quality was verified before each
measurement sequence. However, it has been suggested,
that for correct use the PiCCOplus™ system needs to be rec-
alibrated at intervals of four to six hours when changes of vas-
cular resistance are likely to occur or after major
haemodynamic changes in order to maintain accuracy of car-
diac output readings [4].
For the interpretation of the data presented in this study the
following limitations have to be considered. We assessed car-
diac output in a low-risk cardiac surgical group only. In clinical
practice advanced monitoring techniques are typically used in
patients at risk for major haemodynamic compromise.
In our study we induced cardiac output changes by body posi-
tioning. This approach does not necessarily reflect a clinically
relevant haemodynamically unstable situation. However, head-
down tilting manoeuvres have been increasingly propagated in
Table 2
Haemodynamic variables during the study period
Set Variables Supine 1 Head-up Head-down Supine 2
A FCO (L/minute) 5.5 (0.8) 4.7 (0.7)a 6.4 (1.1)a, b 5.5 (0.8) b, c
PCO (L/minute) 5.4 (0.8) 4.9 (0.8)a 5.8 (0.9)a, b 5.4 (0.9) b, c
ICO (L/minute) 5.7 (1.1) 5.0 (0.9)a 6.1 (1.1)a, b 5.6 (1.1) b, c
HR (beats/minute) 86 (8) 87 (10) 88 (9) 89 (9)
MAP (mmHg) 75 (9) 68 (10)a 77 (10) b 74 (10)
CVP (mmHg) 10 (4) 6 (3)a 11 (4) a, b 8 (3)c
SVR (dyn sec/cm-5) 933 (170) 985 (207) 884 (235) b 953 (145)
B FCO (L/minute) 5.6 (1.0) 4.7 (0.9)a 5.1 (0.9)a, b 5.4 (1.2) b, c
PCO (L/minute) 5.5 (1.2) 4.7 (1.2)a 5.3 (1.4)a, b 5.5 (1.4) b, c
ICO (L/minute) 5.8 (1.1) 4.3 (1.1)a 5.0 (1.3)a, b 5.3 (1.5) b, c
HR (beats/minute) 88 (7) 67 (16) 82 (12) 89 (7)
MAP (mmHg) 76 (5) 74 (11) 72 (7) b 72 (8)
CVP (mmHg) 9 (3) 7 (4)a 10 (3)a, b 8 (4)
SVR (dyn sec/cm-5) 969 (175) 1001 (186) 960 (196) 1008 (195)
CVP = central venous pressure; FCO = cardiac output assessed by the FloTrac/Vigileo™ device; HR = heart rate; ICO = cardiac output 
determined by the intermittent thermodilution; MAP = mean arterial pressure; PCO = cardiac output assessed by the PiCCOplus™ system; SVR 
= systemic vascular resistance. Data are presented as mean (standard deviation).
a P < 0.05 compared with supine 1 position; b P < 0.05 compared with head-up position; c P < 0.05 compared with head-down position.Available online http://ccforum.com/content/13/2/R32
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Figure 3
Bland-Altman analysis for set A: comparison of the FloTrac/Vigileo™ system and intermittent thermodilution Bland-Altman analysis for set A: comparison of the FloTrac/Vigileo™ system and intermittent thermodilution. Solid line = mean bias; dashed lines = 
limits of agreement. 
FCOA = cardiac output assessed by the FloTrac/Vigileo™ system using the software version 1.03; ICO = cardiac output determined by the intermit-
tent thermodilution; PCO = cardiac output assessed by the PiCCOplus™ system.Critical Care    Vol 13 No 2    Senn et al.
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the past few years in order to assess fluid responsiveness
[21]. Moreover, this approach allowed us to perform a more
reliable trend analysis compared with other comparative stud-
ies on cardiac output measurement.
Based on technical restrictions we were not able to simultane-
ously assess cardiac output using both FloTrac™ algorithms in
the same patient group. However, the pre-defined study pro-
tocol was strictly followed in both patient groups and cardiac
output measurements by the reference technique were com-
parable in both data sets.
We did not assess cardiac output in hyperdynamic situations
[22], that is, patients with reduced peripheral resistance.
Therefore, our findings may not be applicable to other situa-
tions and patients other than the population studied.
Conclusions
In conclusion, our study results indicate that the modification
of the FloTrac/Vigileo™ software with a reduced time window
for vascular compliance adjustment resulted in an improved
performance in order to assess cardiac output measurements
and track the related alterations during haemodynamic
changes induced by body positioning in patients after elective
off-pump coronary artery bypass surgery.
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Key messages
￿  Software modification of the FloTrac/Vigileo™ system 
with a reduction of the time window for vascular adjust-
ment from ten to one minute resulted in an improved 
performance of cardiac output measurement during 
haemodynamic changes in patients after cardiac sur-
gery.
￿  The un-calibrated FloTrac/Vigileo™ system in its modi-
fied form allowed a reliable trend analysis when com-
pared with intermittent thermodilution.
￿  Cardiac output can now be reliably assessed with a 
percentage error less than 30% using the FloTrac/Vig-
ileo™ system with an upgraded software version as 
compared with intermittent thermodilution. The PiCCO-
plus™ system showed a comparable performance.
Table 3
Bland-Altman analysis for FCO compared with ICO and PCO compared with ICO
FCO-ICO PCO-ICO
Set A Set B Set A Set B
L/minute %Error L/minute %Error L/minute %Error L/minute %Error
Supine 1 -0.1 (1.6) 28.7 -0.3 (1.2) 20.7 -0.2 (1.4) 24.6 -0.3 (1.2) 20.7
Head-up -0.3 (1.8) 36.0 -0.3 (1.1) 25.6 -0.1 (1.1) 22.0 0.1 (1.0) 23.3
Head-down 0.2 (2.2) 36.1 -0.2 (1.1)a 22.0 -0.3 (1.6) 26.2 -0.4 (1.4) 28.0
Supine 2 0.0 (2.4) 42.8 -0.4 (1.0)a 18.9 -0.2 (1.4) 25.0 -0.3 (1.3) 24.5
Total -0.1 (2.1) 37.5 -0.3 (1.1)a 21.6 -0.2 (1.4) 25.0 -0.2 (1.3) 25.5
FCO = cardiac output assessed by the FloTrac/Vigileo™ device; ICO = cardiac output determined by the intermittent thermodilution; PCO = 
cardiac output assessed by the PiCCOplus™ system. Data are presented as mean bias (limits of agreement). Percentage error (%Error) was 
calculated according to Critchley and Critchley [20]. a P < 0.05 compared with set A.Available online http://ccforum.com/content/13/2/R32
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Figure 4
Bland-Altman analysis for set B: comparison of the PiCCOplus™ system and intermittent thermodilution Bland-Altman analysis for set B: comparison of the PiCCOplus™ system and intermittent thermodilution. Solid line = mean bias; dashed lines = limits 
of agreement. 
FCOB = cardiac output assessed by the FloTrac/Vigileo™ system using the software version 1.07; ICO = cardiac output determined by the intermit-
tent thermodilution; PCO = cardiac output assessed by the PiCCOplus™ system.Critical Care    Vol 13 No 2    Senn et al.
Page 10 of 10
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